ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1703

High Density Genotyping Of Immune-Related Disease Genes Identifies 7 New Susceptibility Loci For Behçet’s Disease

Masaki Takeuchi1,2, Nobuhisa Mizuki2, Akira Meguro2, Michael J. Ombrello3, Colleen Satorius4, Yohei Kirino2, Tatsukata Kawagoe2, Duran Ustek5, Ilknur Tugal-tutkun6, Emire Seyahi7, Yilmaz Ozyazgan7, Shigeaki Ohno8, Atsuhisa Ueda2, Yoshiaki Ishigatsubo2, Ahmet Gül6,9, Daniel L. Kastner4 and Elaine Remmers4, 1Medical Genetics Branch, Inflammation Disease Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 2Yokohama City University Graduate School of Medicine, Yokohama, Japan, 3Translational Genetics and Genomics Unit, National Institute of Arthritis Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, MD, 4Inflammatory Disease Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, 5Institute of Experimental Medicine, Istanbul University, Istanbul, Turkey, 6Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey, 7Cerrahpasa Faculty of Medicine, Istanbul University, Istanbul, Turkey, 8Hokkaido University Graduate School of Medicine, Hokkaido, Japan, 9Department of Internal Medicine, Rheumatology Division, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Autoinflammatory Disease, Behcet's syndrome, IL-1 and polymorphism

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Genetics and Genomics of Rheumatic Disease I

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Genome-wide association studies have revealed susceptibility genes for many genetically complex diseases. The Immunochip is a custom array with 196,524 markers in 186 loci selected from analysis of 12 autoimmune diseases.  It enables dense genotyping of established immune disease-associated loci as well as genotyping of additional suggestive variants identified in immune diseases.  Behçet’s disease (BD) is a systemic vasculitis that manifests with oral ulcers, uveitis, skin inflammation, genital ulcers and inflammation in other organs.  Although HLA-B*51, IL10, IL23R, CCR1, STAT4, KLRC4, and ERAP1have been reported to be susceptibility genes in previous studies, the pathogenesis of BD remains unclear.  The purpose of this study was to perform dense genotyping of loci associated with immune diseases to identify novel susceptibility loci for BD.

Methods:

In this study, 2014 Turkish BD patients and 1826 controls were densely genotyped using the Immunochip.  Samples with call rate > 0.95 and markers with call rate > 0.95, minor allele frequency > 0.01, and Hardy-Weinberg equilibrium P value > 0.00001 were included.  Samples from related individuals with identity by descent pi-hat > 0.18 were excluded and principal components were used to evaluate population stratification.  For novel loci with association test P value < 5×10-6, additional SNPs in the region were imputed using 1000 Genomes data as the reference panel.  Imputed SNPs with info > 0.8 were included in the comprehensive association analysis.  P < 5×10-8 and P < 1.67×10-8were considered thresholds for genome-wide significance in the basic allele test analysis and the three model (additive, dominant, recessive) genotypic analysis, respectively.

Results:

The basic allele association test confirmed 2 loci, IL10 and CCR1, previously associated with BD and identified 4 novel loci, IL1A-IL1B, SCHIP1-IL12A, IRF8, and PTPN1, which exceeded genome-wide significance.  In addition, the FUT2 locus showed dominant model genome-wide significance in the three model genotypic analysis.  Imputation data provided 2 additional novel loci with genome-wide significance, RIPK2 and EGR2.

Conclusion:

This immunochip dense-genotyping study identified 7 new BD susceptibility loci. These results have greatly expanded the list of genes with common variants that influence BD susceptibility.  Some of these new loci implicate important pathways, such as the IL-1 pathway, which may help explain BD pathogenesis and suggest therapeutic targets.

 


Disclosure:

M. Takeuchi,
None;

N. Mizuki,
None;

A. Meguro,
None;

M. J. Ombrello,
None;

C. Satorius,
None;

Y. Kirino,
None;

T. Kawagoe,
None;

D. Ustek,
None;

I. Tugal-tutkun,
None;

E. Seyahi,
None;

Y. Ozyazgan,
None;

S. Ohno,
None;

A. Ueda,
None;

Y. Ishigatsubo,
None;

A. Gül,
None;

D. L. Kastner,
None;

E. Remmers,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/high-density-genotyping-of-immune-related-disease-genes-identifies-7-new-susceptibility-loci-for-behcets-disease/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology